Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Solve C-S bond formation challenges with air-stable indole phosphine ligands. Achieve 90% yield at 0.5 mol% Pd loading. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Solve piperazine cyanation challenges with metal-free visible light catalysis. 83% yield, air atmosphere, no expensive equipment. Scale to 100MT/yr.
Solve supply chain risks with metal-free catalysts and 75-85% yields. Scale 3-trifluoromethyl-4H-benzo[b][1,4]oxazine production safely. Contact for COA/MSDS.
Solve chiral synthesis challenges with this one-pot two-step method. Achieve 95% ee, 80-89% yield, and simplified production for pharmaceutical intermediates.
Solve 16-hour reaction time & environmental pollution in N,N-diallyl-5-methoxytryptamine hydrochloride production. 98%+ purity, 88%+ yield, catalyst recycling. Scale to 100 MT/yr.
Solve axial chiral synthesis challenges with high-yield, mild-condition process. Reduce R&D costs and supply chain risks for asymmetric catalysts.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Solve chiral synthesis challenges with 93% yield and 98:2 er. Our CDMO expertise scales this patent-protected method for stable API supply chains.
97% ee, >95% yield, low-cost industrial production of chiral alpha-hydroxy-beta-keto esters for agrochemicals. Solve supply chain risks with scalable zirconium catalysis.
Discover a one-pot method for 2,3-dichloroquinoxaline derivatives with 90% yield, eliminating intermediate purification and reducing production costs by 30% for pharmaceutical intermediates.
Solve high-cost chiral catalyst production with 99.5% ee, 80% yield, and no toxic reagents. Scale to 100MT/yr with NINGBO INNO PHARMCHEM.
Reduce production costs by 30% with this catalyst achieving >95% ee in asymmetric reactions. Ideal for pharma R&D and procurement teams.
Discover how air-promoted nanopalladium Suzuki coupling in PEG eliminates inert gas needs, reduces costs, and achieves 99% yields for pharmaceutical intermediates.
Solve chiral induction challenges with 97% yield axial diamine synthesis. Reduce R&D costs & scale production for pharma intermediates.
Discover how this novel asymmetric catalytic hydrogenation method enables high-yield, high-ee synthesis of chiral dihydro-9-phenanthrene amine for pharmaceutical applications.
Discover how this novel axial chiral phosphine catalyst enables high-yield, high-enantioselective synthesis for pharmaceutical intermediates, reducing production costs and supply chain risks.
Discover how chiral phosphoric acid catalysis enables high-yield, enantioselective synthesis of axial chiral aryl indoles for cancer drug development and supply chain de-risking.
This innovative one-pot method for triarylmethane compounds offers high yields, low catalyst loading, and easy purification, reducing costs and supply chain risks for drug development.
Discover how N-heterocyclic carbine catalysis enables high-yield, enantioselective synthesis of spiro hydroxyindole pentamethylene beta-lactones for drug development and insecticide production.
Avoid toxic reagents & high catalyst costs in aryl methoxylation. New copper-catalyzed method ensures 36-89% yield with 5% catalyst loading.